PAULA’s Test is a blood test than can help detect lung cancer early – before it has spread.  Smokers and ex-smokers have an up to 1 in 7* chance of developing lung cancer.  Lung cancer is among the most lethal of all malignancies, in part because it is usually diagnosed at a late stage, when the effectiveness of treatment is limited.  Screening for lung cancer can save many lives. If lung cancer is detected before it spreads, a patient has about an 80% survival rate. Once a patient has symptoms, and the cancer has spread, survival is poor.

Our blood test for early detection can help your doctor detect lung cancer early, while it is still possible to do something about it.  The test, called PAULA’s Test, can aid in the risk assessment and early detection of lung cancer. It looks at 4 proteins in the blood which are known to be associated with lung cancer.

The test is recommended for smokers and ex-smokers over 50, who have smoked at pack a day for 20 years or longer, and who currently do not have any symptoms.  Ex-smokers are also at an increased risk if it has been less than 15 years since they quit.

Patients with symptoms, such as a persistent cough, should utilize other diagnostic tools such as CT scans.

PAULA’s Test (an acronym for “Protein Assays Using Lung cancer Analytes”) is named in memory of Paula Shore, the wife of Dr. Ronald Shore, a physician who helped develop the test. Mrs. Shore succumbed to lung cancer in 2005.

How It Works

A blood sample will be drawn at your doctor’s office and sent to Genesys Biolabs’ state and federally certified laboratory, where our proprietary biomarker test will be performed.  By using PAULA’s Test, your doctor can assess your risk for lung cancer at the time the test was taken and consult with you about the need for further diagnostic follow up.